Mazabraud Syndrome
Description
Mazabraud syndrome is a rare primary bone dysplasia (see this term) characterized by the association of fibrous dysplasia with intramuscular myxomas. Fibrous dysplasia (usually polyostotic, sometimes monostotic) occurs during the growth period and can be asymptomatic or can present with pain, skeletal deformities or fractures while intramuscular myxoma, associated with polyostotic fibrous dysplasia (see this term) is usually multifocal, typically occuring in the vicinity of skeletal lesions, and presents in adulthood as a painless soft-tissue mass (most commonly in the thigh). Although it is a benign condition, local recurrences of myxomas after incomplete excision and malignant transformation of a fibrous dysplastic lesion into osteogenic sarcoma have been reported.
Clinical Features
Phenotypes and symptoms related to Mazabraud Syndrome
- Abnormality of the skeletal system
- Skeletal dysplasia
- Recurrent fractures
- Bone pain
- Fibrous dysplasia of the bones
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Mazabraud Syndrome Is also known as myxoma with fibrous dysplasia.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Mazabraud Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Pseudohypoparathyroidism Type 1B.
By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
GNAS
Specificity
100 %
Genes
100 % |
Pseudohypoparathyroidism Type 1A.
By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States).
GNAS
Specificity
100 %
Genes
100 % |
Albright Hereditary Osteodystrophy (GNAS).
By Center for Genetics at Saint Francis Saint Francis Hospital (United States).
GNAS
Specificity
100 %
Genes
100 % |
Platelet Disorders.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RUNX1, STIM1, TBXA2R, TBXAS1, USF1, VPS33B, VWF, WAS, GP6, HPS3, HPS4, CD36, HPS5, DTNBP1, P2RY12, HPS6, MASTL, LYST, VIPAS39, FERMT3 , (...)
View the complete list with 34 more genes
Specificity
2 %
Genes
100 % |
MyeloidDx by NGS.
By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).
RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, FBXW7, CDKN2A, PHF6, ASXL1, CEBPA , (...)
View the complete list with 32 more genes
Specificity
2 %
Genes
100 % |
MyeloidDx by NGS.
By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).
RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, CBLC, FBXW7, CDKN2A, PHF6, CEBPA , (...)
View the complete list with 31 more genes
Specificity
2 %
Genes
100 % |
Monogenic Obesity Sequencing Panel.
By Genetic Services Laboratory University of Chicago (United States).
SDCCAG8, SIM1, UCP3, ARL6, TRIM32, AFF4, PHF6, SETD2, BBS7, TTC8, IFT74, VPS13B, CUL4B, PRMT7, BBS10, BBS12, WDPCP, CEP290, KIDINS220, BBS9 , (...)
View the complete list with 18 more genes
Specificity
3 %
Genes
100 % |
Hypoparathyroidism Deletion/Duplication Panel.
By Genetic Services Laboratory University of Chicago (United States).
STX16, TBCE, TBX1, CASR, CHD7, FAM111A, CYP24A1, AIRE, GATA3, GCM2, GNA11, GNAS, HADHA, HADHB, PDE4D, PRKAR1A, PTH
Specificity
6 %
Genes
100 % |
You can get up to 116 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MENTAL RETARDATION, X-LINKED 21; MRX21 HYPERTHYROIDISM, FAMILIAL GESTATIONAL